Molecular Neurodegeneration

Scope & Guideline

Championing open access for neurodegenerative research.

Introduction

Welcome to your portal for understanding Molecular Neurodegeneration, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMOL NEURODEGENER / Mol. Neurodegener.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Molecular Neurodegeneration focuses on the molecular and cellular mechanisms underlying neurodegenerative diseases, providing a platform for research that integrates various aspects of neurobiology and pathology.
  1. Mechanistic Insights into Neurodegeneration:
    The journal emphasizes understanding the fundamental biological processes that lead to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and other tauopathies. This includes studies on protein misfolding, aggregation, and cellular stress responses.
  2. Immune System Interactions:
    Research often explores the role of the immune system, including microglial activation, neuroinflammation, and the effects of immune modulation on neurodegeneration, highlighting the complex interplay between the nervous and immune systems.
  3. Genetic and Epigenetic Factors:
    The journal covers genetic studies, including genome-wide association studies (GWAS) and investigations into specific genetic variants that contribute to neurodegenerative conditions, as well as epigenetic mechanisms that influence disease progression.
  4. Therapeutic Approaches and Biomarkers:
    Molecular Neurodegeneration presents studies on novel therapeutic strategies, including drug development, immunotherapy, and biomarker identification, aimed at improving diagnosis and treatment outcomes for neurodegenerative diseases.
  5. Cellular and Animal Models:
    The use of advanced cellular and animal models to study disease mechanisms and test therapeutic interventions is a consistent theme, allowing for a better understanding of human neurodegenerative conditions.
Recent publications in Molecular Neurodegeneration highlight several emerging themes that reflect the evolving landscape of neurodegenerative research.
  1. Role of the Gut-Brain Axis:
    There is an increasing focus on the gut microbiome's influence on neurodegeneration, particularly how gut-derived metabolites and inflammation affect brain health and disease progression.
  2. Single-Cell and Multi-Omics Approaches:
    The application of single-cell sequencing and multi-omics strategies is gaining traction, enabling researchers to dissect cellular heterogeneity and molecular pathways involved in neurodegenerative diseases.
  3. Targeted Protein Degradation:
    Emerging strategies involving targeted protein degradation technologies (e.g., AUTOTAC) are being explored as potential therapeutic approaches for clearing pathological protein aggregates.
  4. Advances in RNA Therapeutics:
    Research on RNA-based therapies, including antisense oligonucleotides and RNA modulation techniques, is on the rise, reflecting a shift towards innovative therapeutic modalities.
  5. Neuroinflammation and Microglial Function:
    A significant trend is the deeper exploration of neuroinflammation and the diverse roles of microglia in neurodegeneration, including their contributions to disease progression and potential as therapeutic targets.

Declining or Waning

While certain themes remain strong, others appear to be declining in prominence, reflecting shifts in research focus within the field of neurodegeneration.
  1. Traditional Neuropathology Studies:
    There seems to be a reduced emphasis on classical histopathological studies of neurodegenerative diseases, as research increasingly favors molecular and genetic approaches.
  2. Simple Model Systems:
    The use of basic model organisms or systems that do not adequately recapitulate human disease pathology appears to be waning, with a shift towards more complex models that better mimic human neurodegenerative processes.
  3. Generalized Biomarker Research:
    Research focused solely on generalized biomarkers without specific context or mechanistic insights is becoming less common, as the field moves towards more targeted and disease-specific biomarker studies.
  4. Broad Immunotherapy Approaches:
    There is a noticeable decline in publications focusing on broad-spectrum immunotherapies, with a shift towards more specific and mechanism-based immunomodulatory strategies.

Similar Journals

ASN Neuro

Fostering Discoveries in the Complex World of Brain Function
Publisher: FRONTIERS MEDIA SAISSN: 1759-0914Frequency: 1 issue/year

ASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.

NEUROCHEMISTRY INTERNATIONAL

Pioneering Discoveries in Neurochemistry and Health
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

NATURE NEUROSCIENCE

Illuminating the Complexities of the Nervous System
Publisher: NATURE PORTFOLIOISSN: 1097-6256Frequency: 12 issues/year

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

CELLULAR AND MOLECULAR NEUROBIOLOGY

Exploring the Nexus of Cell Biology and Neuroscience.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0272-4340Frequency: 8 issues/year

CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.

Frontiers in Molecular Neuroscience

Connecting researchers to shape the future of molecular neuroscience.
Publisher: FRONTIERS MEDIA SAISSN: 1662-5099Frequency: 1 issue/year

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.

FASEB BioAdvances

Transforming Insights into Impactful Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

ACTA NEUROPATHOLOGICA

Advancing the Frontiers of Neuropathology
Publisher: SPRINGERISSN: 0001-6322Frequency: 12 issues/year

ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.

Life Science Alliance

Empowering Research, Elevating Knowledge.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Transforming Understanding through Neurobiological Advances
Publisher: WILEYISSN: 0305-1846Frequency: 7 issues/year

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.

SYNAPSE

Exploring the Depths of Neural Communication
Publisher: WILEYISSN: 0887-4476Frequency: 12 issues/year

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.